{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:28:15Z","timestamp":1784147295449,"version":"3.55.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The search for the genetic basis of the leading symptom domains of schizophrenia is of interest. BDNF is a universal neurotrophin that promotes brain development and neuroplasticity. Our aim was to study polymorphisms of the <jats:italic>BDNF<\/jats:italic> gene and serum levels of BDNF in schizophrenia and to analyze the concentration of this marker depending on clinical and genetic characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A clinical and biological examination of 123 patients with paranoid schizophrenia (F20.0, ICD-10) was conducted. The control group consisted of 193 healthy individuals. Genotyping of polymorphisms (rs6265 and rs11030104) was performed by RT-PCR. BDNF concentration was determined using xMAP technology. Statistical data processing was performed in SPSS software.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A lower BDNF concentration was found in schizophrenia patients than in healthy individuals. Clinical characteristics of the disease, such as duration of the disease and leading clinical symptoms do not affect the level of BDNF. The continuous type of course is characterized by a tendency to decrease the BDNF serum concentration compared to the episodic type. The distribution of rs6265 genotypes differed significantly between the groups of schizophrenia patients and healthy individuals. The TT genotype was more common among the patients and had a predisposing effect on schizophrenia. Serum levels of BDNF did not differ between the patients with different genotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results support a potential value of studied BDNF protein and gene as a neurobiological marker for schizophrenia pathogenesis and clinical characteristics. Further case-control studies on the <jats:italic>BDNF<\/jats:italic> gene and peripheral BDNF levels with larger sample sizes and different ethnic groups are needed to better understand the pathogenesis of the schizophrenia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1556079","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:14:27Z","timestamp":1747631667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["BDNF gene polymorphisms and BDNF serum concentration in schizophrenia patients: a pilot study"],"prefix":"10.3389","volume":"16","author":[{"given":"Anastasiia S.","family":"Boiko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Mednova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V.","family":"Mikhalitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Z.","family":"Paderina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Petkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena G.","family":"Kornetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay A.","family":"Bokhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/gpsych-2023-101078","article-title":"The burden of depression, anxiety and schizophrenia among the older population in ageing and aged countries: an analysis of the Global Burden of Disease Study 2019","volume":"37","author":"Cheng","year":"2024","journal-title":"Gen Psychiatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","year":"2014","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/YPG.0000000000000245","article-title":"Schizophrenia in a genomic era: a review from the pathogenesis, genetic and environmental etiology to diagnosis and treatment insights","volume":"30","author":"Zamanpoor","year":"2020","journal-title":"Psychiatr Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/089771503322584628","article-title":"Apoptosis of spinal cord neurons by preventing depletion nicotine attenuates arachidonic acid-induced of neurotrophic factors","volume":"20","author":"Garrido","year":"2003","journal-title":"J Neurotrauma"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/24705470211029254","article-title":"Chronic stress weakens connectivity in the prefrontal cortex: architectural and molecular changes","volume":"5","author":"Woo","year":"2021","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.08.058","article-title":"Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients","volume":"259","author":"Ochi","year":"2019","journal-title":"J Affect Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl Neurodegener"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.04.007","article-title":"Investigation of serum BDNF levels in drug-naive patients with schizophrenia","volume":"32","author":"Rizos","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.schres.2009.12.035","article-title":"Decreased BDNF in patients with antipsychotic na\u00efve first episode schizophrenia","volume":"119","author":"Jindal","year":"2010","journal-title":"Schizophr Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2020.102370","article-title":"Brain-derived neurotrophic factor (BDNF) levels in first-episode schizophrenia and healthy controls: A comparative study","volume":"54","author":"Singh","year":"2020","journal-title":"Asian J Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-1781(02)00127-0","article-title":"Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients","volume":"110","author":"Toyooka","year":"2002","journal-title":"Psychiatry Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2004.05.008","article-title":"Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment","volume":"28","author":"Pirildar","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics","volume":"41","author":"Grillo","year":"2007","journal-title":"J Psychiatr Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.696059","article-title":"Associations between the kynurenine pathway, proinflammatory cytokines, and brain-derived neurotrophic factor in hospitalized patients with chronic schizophrenia: A preliminary study","volume":"12","author":"Okamoto","year":"2021","journal-title":"Front Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3934\/Neuroscience.2023002","article-title":"Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions","volume":"10","author":"Ahmad","year":"2023","journal-title":"AIMS Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.08.025","article-title":"Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia","volume":"61","author":"Gratac\u00f2s","year":"2007","journal-title":"Biol Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2024.03.001","article-title":"Genetic predisposition of BDNF (rs6265) gene is susceptible to Schizophrenia: A prospective study and updated meta-analysis","volume":"39","author":"Vajagathali","year":"2024","journal-title":"Neurol (Engl Ed)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.47391\/jpma-duhs-s05","article-title":"Impact of Brain derived Neurotrophic factor gene polymorphism on its peripheral levels in schizophrenic patients","volume":"74","author":"Bibi","year":"2024","journal-title":"J Pak Med Assoc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709991015","article-title":"Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: Correlation with plasma BDNF and psychopathology","volume":"13","author":"Pillai","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000514126","article-title":"A meta-analysis of brain-derived neurotrophic factor effects on brain volume in schizophrenia: genotype and serum levels","volume":"80","author":"Ahmed","year":"2021","journal-title":"Neuropsychobiology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1283-6","article-title":"Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation","volume":"56","author":"Giacobbo","year":"2019","journal-title":"Molec Neurobiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001507","article-title":"Brain-derived neurotrophic factor: Regulation, effects, and potential clinical relevance","volume":"84","author":"Benarroch","year":"2015","journal-title":"Neurology"},{"key":"B25","article-title":"Brain-Derived Neurotrophic Factor (BDNF) and First-Episode Psychosis. A longitudinal one-year prognosis study","volume":"51","author":"Yelmo-Cruz","year":"2023","journal-title":"Actas Esp Psiquiatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2014.117","article-title":"Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications","volume":"20","author":"Fernandes","year":"2015","journal-title":"Mol Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpsychires.2018.09.007","article-title":"The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis","volume":"106","author":"Rodrigues-Amorim","year":"2018","journal-title":"J Psychiatr Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2005.11.021","article-title":"Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus","volume":"82","author":"Pillai","year":"2006","journal-title":"Schizophr Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.111240","article-title":"Long-term effects of antipsychotics on serum BDNF levels in patients with schizophrenia","volume":"136","author":"Mikulic","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13091395","article-title":"Associations of BDNF\/BDNF-AS SNPs with depression, schizophrenia, and bipolar disorder","volume":"13","author":"Shkundin","year":"2023","journal-title":"J Pers Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.pnpbp.2012.05.014","article-title":"The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain","volume":"39","author":"Zai","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.01.020","article-title":"Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia","volume":"146","author":"Zhang","year":"2013","journal-title":"Schizophr Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/srep45203","article-title":"TOX and ADIPOQ gene polymorphisms are associated with antipsychotic-induced weight gain in han chinese","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pnpbp.2014.01.012","article-title":"The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia","volume":"51","author":"Chen","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.08.002","article-title":"Val66Met functional polymorphism and serum protein level of brain-derived neurotrophic factor (BDNF) in acute episode of schizophrenia and depression","volume":"70","author":"Skibinska","year":"2018","journal-title":"Pharmacol Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112832","article-title":"Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia","volume":"394","author":"Kumar","year":"2020","journal-title":"Behav Brain Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.03.021","article-title":"Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes","volume":"47","author":"Zakharyan","year":"2014","journal-title":"Clin Biochem"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1556079\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:14:28Z","timestamp":1747631668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1556079\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":38,"alternative-id":["10.3389\/fpsyt.2025.1556079"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1556079","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"article-number":"1556079"}}